Risk Stratification at Admission to Identify ST-Segment Elevation Myocardial Infarction Patients Receiving Fibrinolysis Who May Benefit from Early Angioplasty: Insights from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)

被引：0
|
作者：
Yan, Andrew T.
Cantor, Warren J.
Yan, Raymond T.
Borgundvaag, Bjug
Cohen, Eric A.
Dzavik, Vlad
Ducas, John
Tan, Mary
Casanova, Amparo
Goodman, Shaun G.
机构：
[1] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[2] Southlake Reg Hlth Cntr, Newmarket, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
[4] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[5] Sunnybrook Hlth Sci Cntr, Toronto, ON, Canada
[6] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON, Canada
[7] St Boniface Gen Hosp, Winnipeg, MB, Canada
[8] Canadian Heart Rsch Cntr, Toronto, ON, Canada
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Myocardial infarction; STEMI; Angioplasty; Fibrinolytic agents;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A15640
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: An analysis from the CADILLAC trial
    Prasad, A
    Stone, GW
    Aymong, E
    Zimetbaum, PJ
    McLaughlin, M
    Mehran, R
    Garcia, E
    Tcheng, JE
    Cox, DA
    Grines, CL
    Gersh, BJ
    AMERICAN HEART JOURNAL, 2004, 147 (04) : 669 - 674
  • [42] Predictors of Mortality in Non-Anterior ST-segment Elevation Myocardial Infarction: Insights from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial
    Giustino, Gennaro
    Dizon, Joe
    Genereux, Philippe
    Mehran, Roxana
    Goessl, Mario
    Gersh, Bernard J.
    Ayele, Girma M.
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B105 - B105
  • [43] Prevalence and prognostic implications of ST-Segment deviations from ambulatory Holter monitoring after ST-Segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish trial in acute myocardial infarction-2 substudy)
    Idorn, Lars
    Hofsten, Dan Eik
    Wachtell, Kristian
    Molgaard, Henning
    Egstrup, Kenneth
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (06): : 937 - 943
  • [44] Outcomes in Patients With ST-Segment Elevation Acute Myocardial Infarction Treated With Clopidogrel Versus Prasugrel (from the INFUSE-AMI Trial)
    Brener, Sorin J.
    Oldroyd, Keith G.
    Maehara, Akiko
    El-Omar, Magdi
    Witzenbichler, Bernhard
    Xu, Ke
    Mehran, Roxana
    Gibson, Michael
    Stone, Gregg W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (09): : 1457 - 1460
  • [45] Predictors of Left Ventricular Ejection Fraction Improvement After Primary Stenting in ST-Segment Elevation Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial)
    Serrao, Gregory W.
    Lansky, Alexandra J.
    Mehran, Roxana
    Stone, Gregg W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (06): : 678 - 683
  • [46] Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial
    Madhavan, Mahesh V.
    Genereux, Philippe
    Kirtane, Ajay J.
    Xu, Ke
    Witzenbichler, Bernhard
    Mehran, Roxana
    Stone, Gregg W.
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2017, 6 (07) : 650 - 658
  • [47] Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction registry
    Li, Sidong
    Gao, Xiaojin
    Yang, Jingang
    Xu, Haiyan
    Wang, Yang
    Zhao, Yanyan
    Yin, Lu
    Wu, Chao
    Wang, Yi
    Zheng, Yang
    Li, Bao
    Zhang, Xuan
    Ye, Yunqing
    Fu, Rui
    Dong, Qiuting
    Sun, Hui
    Yan, Xinxin
    Wu, Yuan
    Zhang, Jun
    Jin, Chen
    Li, Wei
    Yang, Yuejin
    BMC MEDICINE, 2022, 20 (01)
  • [48] Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction registry
    Sidong Li
    Xiaojin Gao
    Jingang Yang
    Haiyan Xu
    Yang Wang
    Yanyan Zhao
    Lu Yin
    Chao Wu
    Yi Wang
    Yang Zheng
    Bao Li
    Xuan Zhang
    Yunqing Ye
    Rui Fu
    Qiuting Dong
    Hui Sun
    Xinxin Yan
    Yuan Wu
    Jun Zhang
    Chen Jin
    Wei Li
    Yuejin Yang
    BMC Medicine, 20
  • [49] Fibrinolysis Use Among Patients Requiring Interhospital Transfer for ST-Segment Elevation Myocardial Infarction Care A Report From the US National Cardiovascular Data Registry
    Vora, Amit N.
    Holmes, DaJuanicia N.
    Rokos, Ivan
    Roe, Matthew T.
    Granger, Christopher B.
    French, William J.
    Antman, Elliott
    Henry, Timothy D.
    Thomas, Laine
    Bates, Eric R.
    Wang, Tracy Y.
    JAMA INTERNAL MEDICINE, 2015, 175 (02) : 207 - 215
  • [50] Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial
    van Diepen, Sean
    Roe, Matthew T.
    Lopes, Renato D.
    Stebbins, Amanda
    James, Stefan
    Newby, L. Kristin
    Moliterno, David J.
    Neumann, Franz-Josef
    Ezekowitz, Justin A.
    Mahaffey, Kenneth W.
    Hochman, Judith S.
    Hamm, Christian W.
    Armstrong, Paul W.
    Theroux, Pierre
    Granger, Christopher B.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (01) : 106 - 113
12345